Oral type II collagen treatment in early rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 1, 1996, Pages 41-51

  Sieper, Joachim ^a,b,g   Kary, Sonja ^a   Sörensen, Helmut ^c   Alten, Rieke ^d   Eggens, Ulrich ^b   Hüge, Werner ^e   Hiepe, Falk ^f   Kühne, Andrea ^a   Listing, Joachim ^a   Ulbrich, Norbert ^a   Braun, Jürgen ^b   Zink, Angela ^a   Mitchison, Nicholas Avrion ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Immanuel Hospital and Rheumaklinik Berlin Buch   (Germany)

^d Schlossparkklinik   (Germany)

^e Rheumaklinik Berlin Buch   (Germany)

^f HUMBOLDT UNIVERSITY   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

ADULT; ARTICLE; BONE EROSION; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANIMALS; ARTHRITIS, RHEUMATOID; CATTLE; COLLAGEN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030042970     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390106     Document Type: Article

References (53)

1. Sieper J, Mitchison AN: Therapy with oral collagen type II as new possibility for selective immunosuppression in the therapy of rheumatoid arthritis. Z Rheumatol 53:53-58, 1994
2. Weiner HL, Friedman A, Miller A. Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA: Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunul 12:809-837, 1994
3. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A 83:7443-7446, 1986
4. Zhang JZ, Lee CSY, Lider O, Weiner HL: Suppression of adjuvans arthritis in Lewis rats by oral administration of type II collagen. J Immunol 145:2489-2493, 1990
5. Poole AR: Cartilage in health and disease. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea & Febiger, 1993
6. Prockop DJ, Williams CJ, Vandenberg P: Collagen in normal and diseased connective tissue. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea & Febiger, 1993
7. Desai BV, Dixit S, Pope RM: Limited proliferative response to type II collagen in rheumatoid arthritis. J Rheumatol 16:1310-1314, 1989
8. Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, Fujii K, Sagara M, Kobayashi S, Goto M, Nishioka K, Miyasaka N, Nagai Y: Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 33: 1493-1500, 1990
9. Miller A, Lider O, Weiner HL: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791-798, 1991
10. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
11. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis (editorial). Arthritis Rheum 35:729-735, 1992
12. Firestein GS, Zvaifler NJ: The role of T cells in rheumatoid arthritis. Ann Rheum Dis 52:765, 1993
13. Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91:8562-8566, 1994
14. Lindblad S, Ulfgren A-K, Klareskog L, Andersson U: Detection of cytokine-producing cells in the synovial membrane in rheumatoid arthritis (abstract). Arthritis Rheum 37 (suppl 9): S193, 1994
15. Steiner G, Akrad N, Kunaver M, Gal A, Wessely M, Zenz P, Smolen JS: Production of cytokines by T cells in RA synovial membranes. Clin Rheumatol 14:236, 1995
16. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation to inflammatory cytokine and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin expression in the brain. J Exp Med 176:1355-1364, 1992
17. Shehadeh NN, La Rosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhihibiton of autoimmune diabetes. J Autoimmun 6:291-300, 1993
18. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4+ T cells in the pathogenesis of organ specific autoimmune diseases. Immunol Today 16:34-38, 1995
19. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovich TL: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:97-99, 1993
20. Bessis N, Boissier M-C, Caput D, Fradelizi D, Fournier C: IL-4 or IL-13 transfected xenogenic fibroblasts in the treatment of collagen induced arthritis in mice. Clin Rheumatol 14:261, 1995
21. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730, 1993
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
23. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36:729-740, 1993
24. Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLC: Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48, 1995
25. Raspe H-H, Kindel P, Vesterling K, Kohlmann T: Die Entwicklung der Funktionskapazität und der Schmerzintensität von 81 cP-Patienten unter einer Behandlung mit Azulfidine RA oder Aurothioglucose. Z Rheumatol 46:71-75, 1987
26. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393-406, 1968
27. Olerup O; Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225-35, 1992
28. Blasczyk R, van Lessen A, Schwella N, Huhn D, Salama A: A novel HLA DR 13 allele (DRB1* 1314) identified by single-strand conformation polymorphism analysis and confirmed by direct sequencing. Hum Immunol 43:303-312, 1995
29. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C. Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-735, 1995
30. Ricard-Blum S, Tiollier J, Garrone R, Herbage D: Further biochemical and physiochemical characterization of minor disulfide-bonded (type IX) collagen, extracted from foetal calf cartilage. J Cell Biochem 27:147-158, 1985
31. Boissier M-C, Chiocchia G, Ronziere M-C, Herbage D, Fournier C: Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum 33:1-8, 1990
32. O'Brien PC: Procedures for comparing samples with multiple endpoints. Biometrics 40:1079-1087, 1984
33. Ollier W, Thomson W: Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 18:741-759, 1992
34. Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308-1315, 1981
35. Bloch K, Bloch D, Stearns M, Walker WA: Intestinal uptake of macromolecules. VI. Uptake of protein antigen in vivo in normal rats and in rats infected with Nippostrongylus brasiliensis or subjected to mild systemic anaphylaxis. Gastroenterology 77:1039-1044, 1977
36. Curtis CH, Gall DG: Macromolecular transport by rat gastric mucosa. Am J Physiol 257:G1033-G1040, 1992
37. Hanson D, Roy M, Green GM, Miller S: Inhibition of orally-induced immune tolerance im mice by prefeeding an endopeptidase inhibitor. Reg Immunol 5:76-74, 1993
38. Michael JG: The role of digestive enzymes in orally induced immune tolerance. Immunol Invest 18:1049-1054, 1989
39. Metzler B, Wraith DC: Inhibiton of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalogenic peptide: influence of MHC binding affinity. Int Immunol 5:1159-1165, 1993
40. Bjarnason I, Williams P, So A, Zanelli GD, Levi A J, Gumpel JM, Peters TJ, Ansell B: Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 2:1171-1173, 1984
41. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ: Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93:480-489, 1987
42. Bradley SM, King B, Troughton PR, Gooi HC, Bird HA, Wright V: Clostridium perfringens and antibody responses to its antigen in arthritis patients on and off non-steroidal anti-inflammatory drugs. Br J Rheumatol 32:940-941, 1993
43. Kanerud L, Scheynius A, Nord CE, Haftström I: Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. Br J Rheumatol 33:1039-1048, 1994
44. Peltonen R, Kjeldsen-Kragh J, Haugen M, Tuominen J, Toivanen P, Forre O, Eerola E: Changes of faecal flora in rheumatoid arthritis during fasting and one-year vegetarian diet. Br J Rheumatol 33:638-643, 1994
45. Khoury SJ, Lider O, Al-Sabbagh A, Weiner HL: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol 131:302-310, 1990
46. Eerola E, Möttönen T, Hannonen P, Luukkainen R, Kantola I, Vuori K, Tuominen J, Toivanen P: Intestinal flora in early rheumatoid arthritis. Br J Rheumatol 33:1030-1038, 1994
47. Zhang Z, Michael JG: Orally inducible immune responsiveness is abrogated by IFNγ treatment. J Immunol 144:4163-4165, 1990
48. Clerici M, Shearer GM: The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575-581, 1994
49. Nishimura M, Kermode AG, Clerici M, Shearer GM, Berzofsky JA, Uchiyama T, Wiktor SZ, Pate E, Maloney B, Manns A, Blattner W, Jacobson S: Demonstration of human T lymphotropic virus type I (HTLV-1)-specific T cell responses from sero-negative and polymerase chain reaction negative persons to HTLV-1. J Infect Dis 170:334-338, 1994
50. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, Tariguchi M, Schultz T, McMichael A, Whittle H: HIV-specific cytotoxic T-cells in HTV-exposed but uninfected Gambian women. Nature Med 1:59-64, 1995
51. Dietrich A, Mitchison NA, Raynavolgyi E, Schneider SC: Primed lymphocytes are boosted by type II collagen of their hosts after adoptive transfer. J Autoimmun 7:601-609, 1994
52. Santos LMB, Al-Sabbagh A, Londono A, Weiner HL: Oral tolerance to myelin basic protein induces regulatory TGF-β secreting cells in Peyer's patches of SJL mice. Cell Immunol 157:439-447, 1994
53. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F: The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498-502, 1992